Viridian Therapeutics, Inc./DE (VRDN)

SEC filing

Viridian Therapeutics, Inc./DE

VRDN · CIK 1590750

4 · Aug 20, 2026 · Chief Legal Officer Tousignant Jennifer sold 14.21K shares at $24.50/share ($348.2K); exercised options for 20K shares

Chief Legal Officer Tousignant Jennifer sold 14.21K shares at $24.50/share ($348.2K); exercised options for 20K shares

Could not load the primary document from EDGAR (SEC rate limit, timeout, or temporary upstream error). Refresh in a minute, or use View on SEC.gov.